Fuente: World Intellectual Property Organization Intellectual Property Valuation in Biotechnology and Pharmaceuticals delves into advanced valuation methods such as risk-adjusted NPV and real options analysis, tailored to the unique dynamics of the biotechnology and pharmaceutical sectors. Using case study examples, the guide explores the multi-stage development process, providing tools to evaluate licensing, milestones and market exclusivity scenarios effectively.